Table 1.
% change in HAA (95% CI)* | P value | |
---|---|---|
Total cholesterol | −1.32 (−1.89 to −0.75) | <0.001 |
| ||
HDL-C, mg/dL | −2.12 (−2.79 to −1.44) | <0.001 |
LDL-C, mg/dL | −0.84 (−1.41 to −0.28) | 0.004 |
Triglycerides | −0.82 (−1.45 to −0.18) | 0.01 |
| ||
Large HDL, 9.4–14 nm | −1.10 (−1.93 to −0.26) | 0.01 |
Medium HDL, 8.2–9.4 nm | −2.56 (−3.31 to −1.80) | <0.001 |
Small HDL, 7.3–8.2 nm | −2.69 (−3.44 to −1.94) | <0.001 |
| ||
Large LDL, 20.5–23 nm | −1.36 (−2.06 to −0.66) | <0.001 |
Small LDL, 18–20.5 nm | −0.73 (−1.56 to 0.11) | 0.09 |
| ||
Apolipoprotein A-1 | −1.66 (−2.36 to −0.97) | <0.001 |
Apolipoprotein B | −0.69 (−1.37 to −0.01) | 0.048 |
Solid lines separate distinct models. Each model includes all exposure variables listed and is additionally adjusted for age, gender, race/ethnicity, educational attainment, height, body mass index, waist circumference, smoking status, cigarette pack-years, glomerular filtration rate, diuretic use, statin use, presence of hypertension, presence of diabetes mellitus, coronary artery calcium, study site, milliampere dose, total volume imaged lung, percent emphysema on CT, interleukin-6 and c-reactive protein.
Reported per standard deviation in each exposure variable.